Sandbox Reserved 1777: Difference between revisions

Line 23:

==MRAS==

<scene name='95/952705/Mras_structure/4'>MRAS</scene> is a monomeric GTPase and is anchored in the cell membrane by a C-terminal S-Farnesyl cysteine carboxylmethyl ester '''(cite- Zhou)'''. When MRAS binds GTP, it becomes active ~~and can only~~ bind the complex ~~once activated~~ <ref name="Hauseman" />. MRAS is a subvariant of the RAS protein and therefore shares most of its regulatory and effector interactions<Ref name= 'Young'>Young, L., Rodriguez-Viciana, P. MRAS: A Close but Understudied Member of the RAS Family. Cold Spring Harbor Perspectives in Medicine (2018). doi: 10.1101/cshperspect.a033621. [https://perspectivesinmedicine.cshlp.org/content/8/12/a033621.full.pdf+html. DOI: 0.1101/cshperspect.a033621]. </Ref>. While other RAS variants bind in complex with SHOC2 and PP1 to allow it to have phosphatase activity, MRAS binds the tightest.

<scene name='95/952705/Mras_structure/4'>MRAS</scene> is a monomeric GTPase and is anchored in the cell membrane by a C-terminal S-Farnesyl cysteine carboxylmethyl ester '''(cite- Zhou)'''. When MRAS binds GTP, it becomes active, which allows MRAS to bind the rest of the complex<ref name="Hauseman" />. MRAS is a subvariant of the RAS protein and therefore shares most of its regulatory and effector interactions<Ref name= 'Young'>Young, L., Rodriguez-Viciana, P. MRAS: A Close but Understudied Member of the RAS Family. Cold Spring Harbor Perspectives in Medicine (2018). doi: 10.1101/cshperspect.a033621. [https://perspectivesinmedicine.cshlp.org/content/8/12/a033621.full.pdf+html. DOI: 0.1101/cshperspect.a033621]. </Ref>. While other RAS variants bind in complex with SHOC2 and PP1 to allow it to have phosphatase activity, MRAS binds the tightest.

===Switch I and II===

Sandbox Reserved 1777: Difference between revisions

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 23: / Line 23: @@
 ==MRAS==
-<scene name='95/952705/Mras_structure/4'>MRAS</scene> is a monomeric GTPase and is anchored in the cell membrane by a C-terminal S-Farnesyl cysteine carboxylmethyl ester '''(cite- Zhou)'''. When MRAS binds GTP, it becomes active and can only bind the complex once activated <ref name="Hauseman" />. MRAS is a subvariant of the RAS protein and therefore shares most of its regulatory and effector interactions<Ref name= 'Young'>Young, L., Rodriguez-Viciana, P. MRAS: A Close but Understudied Member of the RAS Family. Cold Spring Harbor Perspectives in Medicine (2018). doi: 10.1101/cshperspect.a033621. [https://perspectivesinmedicine.cshlp.org/content/8/12/a033621.full.pdf+html. DOI: 0.1101/cshperspect.a033621]. </Ref>. While other RAS variants bind in complex with SHOC2 and PP1 to allow it to have phosphatase activity, MRAS binds the tightest.
+<scene name='95/952705/Mras_structure/4'>MRAS</scene> is a monomeric GTPase and is anchored in the cell membrane by a C-terminal S-Farnesyl cysteine carboxylmethyl ester '''(cite- Zhou)'''. When MRAS binds GTP, it becomes active, which allows MRAS to bind the rest of the complex<ref name="Hauseman" />. MRAS is a subvariant of the RAS protein and therefore shares most of its regulatory and effector interactions<Ref name= 'Young'>Young, L., Rodriguez-Viciana, P. MRAS: A Close but Understudied Member of the RAS Family. Cold Spring Harbor Perspectives in Medicine (2018). doi: 10.1101/cshperspect.a033621. [https://perspectivesinmedicine.cshlp.org/content/8/12/a033621.full.pdf+html. DOI: 0.1101/cshperspect.a033621]. </Ref>. While other RAS variants bind in complex with SHOC2 and PP1 to allow it to have phosphatase activity, MRAS binds the tightest.
 ===Switch I and II===